First they treated diabetes. Then obesity. Now GLP-1 drugs are being tested on a range of other diseases too. Though the US economy is roaring, many Americans are glum about its prospects. How could that affect the election (9:02)? And our podcast on why Chinese migrants are making perilous journeys through the jungle to reach America (16:55).Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.
Top comments
Join Jason Palmer and Rosie Blau for noise-cancelling news and analysis from The Economist's global network of correspondents. Every weekday this award-winning podcast picks three stories shaping your world—the big shifts in politics, business and culture, plus things you never knew you needed to know. On Saturdays, download The Weekend Intelligence to dive deep into a single story, vividly told. If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription.For more information about Economist Podcasts+, including how to get access, please visit our FAQs page at htt...